Walleye Capital LLC Otonomy, Inc. Transaction History

Walleye Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Mar 03, 2022	SELL	$1.69 - $2.31 $160,308 - $219,119	-94,857 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$1.22 - $2.2 $110,596 - $199,436	-90,653 Reduced 48.87%	94,857 $182,000
Q2 2021 Aug 16, 2021	BUY	$2.06 - $2.67 $382,150 - $495,311	185,510 New	185,510 $414,000
Q4 2020 Feb 16, 2021	SELL	$3.48 - $6.47 $66,923 - $124,424	-19,231 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$3.16 - $4.36 $17,029 - $23,496	5,389 Added 38.93%	19,231 $78,000
Q2 2020 Aug 14, 2020	BUY	$1.87 - $3.84 $25,884 - $53,153	13,842 New	13,842 $50,000

Ticker OTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,990,400
Description
Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.